IL146467A0 - Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma - Google Patents

Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma

Info

Publication number
IL146467A0
IL146467A0 IL14646700A IL14646700A IL146467A0 IL 146467 A0 IL146467 A0 IL 146467A0 IL 14646700 A IL14646700 A IL 14646700A IL 14646700 A IL14646700 A IL 14646700A IL 146467 A0 IL146467 A0 IL 146467A0
Authority
IL
Israel
Prior art keywords
gliobastoma
treating
release
anticancer agent
biodegradable microspheres
Prior art date
Application number
IL14646700A
Other languages
English (en)
Original Assignee
Prod Ethiques Ethypharm Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prod Ethiques Ethypharm Sa Lab filed Critical Prod Ethiques Ethypharm Sa Lab
Publication of IL146467A0 publication Critical patent/IL146467A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14646700A 1999-05-17 2000-05-17 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma IL146467A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9906207A FR2793684B1 (fr) 1999-05-17 1999-05-17 Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
PCT/FR2000/001315 WO2000069413A1 (fr) 1999-05-17 2000-05-17 Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome

Publications (1)

Publication Number Publication Date
IL146467A0 true IL146467A0 (en) 2002-07-25

Family

ID=9545636

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14646700A IL146467A0 (en) 1999-05-17 2000-05-17 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
IL146467A IL146467A (en) 1999-05-17 2001-11-13 Use of biodegradable microspheres that release anticancer agents to treat glioblastoma

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL146467A IL146467A (en) 1999-05-17 2001-11-13 Use of biodegradable microspheres that release anticancer agents to treat glioblastoma

Country Status (30)

Country Link
US (2) US6803052B2 (es)
EP (2) EP1053746B1 (es)
JP (1) JP5230045B2 (es)
KR (1) KR100649948B1 (es)
CN (1) CN1210020C (es)
AR (1) AR024008A1 (es)
AT (1) ATE228353T1 (es)
AU (1) AU775320B2 (es)
BG (1) BG64936B1 (es)
BR (1) BR0010648A (es)
CA (1) CA2388656C (es)
CZ (1) CZ20014137A3 (es)
DE (1) DE60000842T2 (es)
DK (1) DK1053746T3 (es)
EA (1) EA004943B1 (es)
ES (1) ES2185544T3 (es)
FR (1) FR2793684B1 (es)
HK (1) HK1047044B (es)
HU (1) HUP0201224A3 (es)
IL (2) IL146467A0 (es)
MX (1) MXPA01011919A (es)
NO (1) NO331686B1 (es)
NZ (1) NZ515515A (es)
PL (1) PL201614B1 (es)
PT (1) PT1053746E (es)
SI (1) SI1053746T1 (es)
SK (1) SK16342001A3 (es)
TW (1) TWI229608B (es)
WO (1) WO2000069413A1 (es)
ZA (1) ZA200109415B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6570600A (en) 1999-08-05 2001-03-05 Map Medizin-Technologie Gmbh Device for supplying a respiratory gas, humidifying device, respiratory gas tube, and connecting device therefor
AUPR098300A0 (en) 2000-10-25 2000-11-16 Sirtex Medical Limited Polymer based radionuclide containing microspheres
JP2002154963A (ja) * 2000-11-14 2002-05-28 Yakult Honsha Co Ltd 徐放性抗腫瘍剤
US20020081339A1 (en) * 2000-12-22 2002-06-27 Philippe Menei Treatment of inoperable tumors by stereotactic injection of microspheres
MXPA03010672A (es) 2001-05-23 2004-03-02 Tanabe Seiyaku Co Composicion para el tratamiento regenerativo de enfermedades del cartilago.
JP4510384B2 (ja) 2001-05-23 2010-07-21 田辺三菱製薬株式会社 骨折治癒促進用組成物
BRPI0210722B8 (pt) 2001-06-29 2021-06-22 Medgraft Microtech Inc implantes injetáveis biodegradáveis e métodos relacionados de produção e uso
UA77999C2 (en) * 2001-12-10 2007-02-15 Thymosin-alpha 1 for treatment of malignant glioblastoma
EP2075256A2 (en) 2002-01-14 2009-07-01 William Herman Multispecific binding molecules
US8986737B2 (en) 2002-09-05 2015-03-24 Wm. Marsh Rice University Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
ATE517649T1 (de) 2003-06-20 2011-08-15 Resmed Ltd Atemgas-gerät mit befeuchter
WO2005023293A1 (en) * 2003-09-09 2005-03-17 Pohang University Of Science And Technology Vaccine composition comprising il-12 adjuvant encapsulated in controlled-release microsphere
EP1732594A4 (en) * 2004-03-18 2007-10-17 St Lukes Hospital METHOD FOR THE ADMINISTRATION OF AGENTS WITH DELAYED RELEASE
JP4929159B2 (ja) * 2004-04-16 2012-05-09 ヌーヴ セラピュティクス、インコーポレイテッド 画像誘導組織切除を改善するための装置
US8088413B2 (en) * 2004-04-16 2012-01-03 Nuvue Therapeutics, Inc. Methods for improved cryo-chemotherapy tissue ablation
AU2005281483B2 (en) 2004-09-07 2008-11-27 Biocompatibles Uk Limited Drug delivery from embolic agents
US8702580B2 (en) * 2004-10-06 2014-04-22 Brainlab Ag Method and device for assisting in a tissue treatment
CN100386115C (zh) * 2004-10-14 2008-05-07 孔庆忠 一种抗癌药物组合物
CN1299685C (zh) * 2005-01-26 2007-02-14 上海大学 氟尿嘧啶载药微球及其制备方法
CN100340297C (zh) * 2005-02-03 2007-10-03 山东蓝金生物工程有限公司 抗癌体内植入剂
CN100464785C (zh) * 2005-08-30 2009-03-04 孔庆忠 一种抗癌药物缓释注射剂及其应用
CN1923282B (zh) * 2005-08-30 2010-05-05 孔庆忠 一种含激素类药物的抗癌缓释注射剂
CN1923281B (zh) * 2005-08-30 2010-05-05 孔庆忠 一种含植物生物碱的抗癌缓释注射剂
CN1923173B (zh) * 2006-02-24 2010-05-19 济南康泉医药科技有限公司 一种同载抗癌抗生素及其增效剂的抗癌药物缓释剂
US20090036380A1 (en) * 2006-03-14 2009-02-05 Yeda Research And Development Co., Ltd. Composition And Method For Brain Tumor Therapy
CN100464736C (zh) * 2006-03-17 2009-03-04 山东蓝金生物工程有限公司 同载抗代谢药物及其增效剂的抗癌缓释注射剂
EP1985286A1 (en) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Microspheres for treatment of brain tumours
CA2858315C (en) 2011-12-13 2020-05-12 Engeneic Molecular Delivery Pty Ltd Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
US10342769B2 (en) 2014-11-14 2019-07-09 Navinta Iii Inc Carmustine pharmaceutical composition
WO2017083717A1 (en) * 2015-11-11 2017-05-18 Qrono, Inc. Sustained release pharmaceutical compositions and methods of use
PL3474820T3 (pl) 2017-08-24 2024-05-13 Novo Nordisk A/S Kompozycje glp-1 i ich zastosowania
TW202140063A (zh) 2020-02-18 2021-11-01 丹麥商諾佛 儂迪克股份有限公司 醫藥配方

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693905B1 (fr) * 1992-07-27 1994-09-02 Rhone Merieux Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
NZ260909A (en) * 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
US5626862A (en) * 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
EP0938333B1 (en) * 1996-10-16 2004-02-04 Regeneron Pharmaceuticals, Inc. Method of enhancing the delivery of growth factors
TW519543B (en) * 1997-03-31 2003-02-01 Toray Industries Quinolinomorphinan derivative and pharmaceutical composition for curing-preventing cerebral disorder
KR20010031103A (ko) * 1997-10-14 2001-04-16 버틀러 그레고리 비. 네우레굴린을 사용하는 치료요법적 방법

Also Published As

Publication number Publication date
ATE228353T1 (de) 2002-12-15
KR20020000178A (ko) 2002-01-04
FR2793684A1 (fr) 2000-11-24
MXPA01011919A (es) 2002-05-06
PL352372A1 (en) 2003-08-25
SI1053746T1 (en) 2003-04-30
HUP0201224A3 (en) 2004-05-28
EP1228755A1 (fr) 2002-08-07
NO20015501D0 (no) 2001-11-09
AU775320B2 (en) 2004-07-29
BG106106A (en) 2002-05-31
SK16342001A3 (sk) 2002-08-06
US20020051749A1 (en) 2002-05-02
HK1047044B (zh) 2005-12-23
DE60000842D1 (de) 2003-01-09
HK1047044A1 (en) 2003-02-07
NO20015501L (no) 2002-01-09
PT1053746E (pt) 2003-04-30
ES2185544T3 (es) 2003-05-01
DK1053746T3 (da) 2003-03-31
EP1053746B1 (fr) 2002-11-27
NZ515515A (en) 2004-02-27
EP1053746A1 (fr) 2000-11-22
WO2000069413A1 (fr) 2000-11-23
JP2002544219A (ja) 2002-12-24
US20030175356A1 (en) 2003-09-18
BR0010648A (pt) 2002-02-19
US6803052B2 (en) 2004-10-12
IL146467A (en) 2006-06-11
BG64936B1 (bg) 2006-10-31
CN1210020C (zh) 2005-07-13
JP5230045B2 (ja) 2013-07-10
CA2388656A1 (fr) 2000-11-23
ZA200109415B (en) 2003-01-29
EA004943B1 (ru) 2004-10-28
AR024008A1 (es) 2002-09-04
CZ20014137A3 (cs) 2002-06-12
NO331686B1 (no) 2012-02-20
CA2388656C (fr) 2011-04-26
PL201614B1 (pl) 2009-04-30
KR100649948B1 (ko) 2006-11-24
HUP0201224A2 (hu) 2002-11-28
EA200101206A1 (ru) 2002-04-25
US7041241B2 (en) 2006-05-09
AU4764100A (en) 2000-12-05
DE60000842T2 (de) 2003-08-28
CN1356892A (zh) 2002-07-03
FR2793684B1 (fr) 2001-08-10
TWI229608B (en) 2005-03-21

Similar Documents

Publication Publication Date Title
HUP0201224A3 (en) Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
EP1205459A4 (en) GAS-CREATING COMPOSITION FOR BELTS
EP1189597A4 (en) COMPOSITIONS USING AN OIL CORE FOR DELAYED RELEASE HYDROPHOLE MEDICAMENTS
PL352931A1 (en) Compositions and uses of et743 for treating cancer
GB0216124D0 (en) Encapsulated time release additive for absorbent articles
EP1225971A4 (en) CONTROLLED RELEASE OF SUBSTANCES
IL149107A0 (en) Formulation of substituted benzimidazoles
AU6510400A (en) Slow release microspheres
HUP0103807A3 (en) Device for dispersal of fluidized powder
IL144603A0 (en) Controlled release formulation for treating copd
SG92610A1 (en) The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis
HUP0200288A3 (en) Use of pde4 for treating copd
GB0029008D0 (en) Release agent delivery system and method for printer devices
GB9904485D0 (en) Method for protecting and/or controlled release of active ingredient
EP1086921A4 (en) LIFT SAFETY DEVICE
GB2322867B (en) Release agent
GB9911546D0 (en) Release of poorly soluble agents
GB0124327D0 (en) Spring loaded hydraulic release brake
AU5305500A (en) Modified biodegradable polyester microspheres for stabilizing and improving the release profile of drugs encapsulated within the microspheres
EP1218025A4 (en) USE OF MULLER CHANNEL INHIBITION SUBSTANCE FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS CHARACTERIZED BY EXCESS ANDROGENES
GB9921062D0 (en) Use of cholestrol-lowering agent
GB9908962D0 (en) Calcified microspheres
TW449230U (en) Improved through-hole pad of PCB
EP1210077A4 (en) COMPOSITION AND SYSTEMS FOR THE TREATMENT OF HYPERPIGMENTATION
TW391404U (en) Brake device of stroller

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed